Federico Grau is CEO of Madeinplant, a pioneering plant bioengineering company that develops and applies precision biotechnology tools to create plant varieties designed to address the challenges of tomorrow, today.
Federico specializes in molecular development projects and gene editing using the CRISPR/Cas9 technology.
Her mission is to transfer knowledge and technology to industry, with a strong focus on the valorization of research in plant biotechnology and the development of biotechnological tools for use in production processes. Her work involves the design, planning, and management of R&D projects for the private sector.